Recruitment |
· Need for culturally diverse recruitment materials |
|
· Need for Age-appropriate recruitment strategies |
Consent/Assent |
· Requirement of parental/guardian consent for minors |
|
· Incorporation of Assent procedures for children |
Intervention Selection |
· Difficulty in maintaining consistency of intervention therapy due to differences in dosing and drug availability |
Control Selection |
· Limitations in the use of placebo controls for children |
Outcome Measurement |
· Dependence on proxy reporting of outcomes for children |
|
· Dearth of cross-age instruments to measure quality of life, asthma control, symptoms and exacerbations |
Participant Growth & Development |
· Need to account for physical growth (e.g., weight, height) of pediatric participants |
Physical Limitations in Data Collection |
· Physical and developmental limits for testing and data collection (e.g., phlebotomy, spirometry, sputum induction) |
|
· Increased safety restrictions in testing of children (e.g., methacholine bronchoprovocation) |
Consideration of Long-term Effects |
· Careful monitoring and follow-up for long term developmental effects in children |
Reporting of Results |
· Determination of how data across ages will be subdivided (e.g., age cut-offs, including adolescents as adults or children) |